Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorpropamide-induced changes in patients with hyperparathyroidism.

P J Numann, N Breslau, A M Moses

    Surgery
    |February 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression.

    Molecular psychiatry·2017
    Same author

    Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.

    Molecular psychiatry·2015
    Same author

    Latent classes of childhood trauma exposure predict the development of behavioral health outcomes in adolescence and young adulthood.

    Psychological medicine·2015
    Same author

    Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders.

    Psychological medicine·2014
    Same author

    Bone quality assessment in type 2 diabetes mellitus.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
    Same author

    Childhood maltreatment, juvenile disorders and adult post-traumatic stress disorder: a prospective investigation.

    Psychological medicine·2013

    Chlorpropamide treatment in primary hyperparathyroidism patients increased calcium and sodium excretion, lowering serum calcium levels. This drug showed potential for long-term management in select patients.

    Area of Science:

    • Endocrinology
    • Metabolic Disorders

    Background:

    • Primary hyperparathyroidism is characterized by elevated serum calcium levels.
    • Management often involves surgical intervention, but medical options are explored for non-surgical candidates.

    Purpose of the Study:

    • To investigate the effects of chlorpropamide on calcium balance in patients with primary hyperparathyroidism.
    • To assess the efficacy of chlorpropamide in lowering serum calcium levels and improving symptoms.

    Main Methods:

    • Ten patients with primary hyperparathyroidism were studied on a controlled calcium and sodium diet.
    • Calcium and sodium excretion, along with cyclic adenosine monophosphate (AMP) excretion, were measured over control and treatment periods with chlorpropamide.

    Main Results:

    Related Experiment Videos

    • Chlorpropamide significantly increased urinary calcium and sodium excretion.
    • A decrease in cyclic adenosine monophosphate (AMP) excretion was observed.
    • Serum calcium levels decreased in six patients; three with diabetes received long-term chlorpropamide, experiencing sustained calcium lowering and symptom improvement.

    Conclusions:

    • Chlorpropamide alters calcium and sodium excretion and may lower serum calcium in primary hyperparathyroidism.
    • Long-term chlorpropamide therapy demonstrated potential benefits in select patients unable to undergo surgery.
    • Further research is needed to elucidate the mechanisms linking chlorpropamide-induced changes in calcium, sodium, and cyclic AMP excretion.